Polymorphisms in TLR5 (rs5744174/F616L) have also been associated with increased survival through their effects in reducing cytokine IL-6 levels [40], which has been linked with a disadvantageous prognosis through IL-6 interaction with STAT3 in CRC [41]. Here, IL6 is linked to colorectal carcinoma.